Wouter de Graaff,Harm Veenstra,Titia Martine Truce Mulders
申请号：
US14036252
公开号：
US20140296833A1
申请日:
2013.11.06
申请国别(地区):
US
年份:
2014
代理人:
摘要：
An intrauterine system is disclosed for use in the treatment of dysfunctional uterine bleeding； menorraghia； dysmenorrhoea； endometriosis； uterine fibroids； climacteric complaints； osteoporosis； and urogenital atrophy. The system is formed by a frame defining an interior space for receipt of a deposit of a therapeutically effective dose of a biologically active compound. The frame has an open structure allowing access to a substantial part of an outer surface of the deposit, and the deposit has a rate controlling structure that controls a rate of release of the compound within the uterus. One or more retention elements are provided on the frame for retaining the frame within the uterus of a female mammal.
